Akamis Bio (Venture)
Funding Details
- Awarder
- Inbox
- Date Award
- December 17, 2024
- Vertical
- Oncology
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Organizations Involved
- Merck, Cancer Research Institute
- Founders
- Howard Davis, PhD
- Company Description
- Akamis Bio is a clinical-stage oncology company.
- Market
- Immunotherapy for solid tumors
- Location
- Cambridge, MA, USA
- Coinvestors
- Sedgwick Yard